Lemonex Competitors and Similar CompaniesClear all

Lemonex's competitors and similar companies include Clovis Oncology, CureVac, Celltrion Healthcare and 3sbio.
Lemonex
Lemonex
Lemonex (레모넥스) is a company that focuses on the development and commercialization of cancer immunotherapeutics, antibody therapeutics, and gene therapeutics.
Clovis Oncology
Clovis Oncology
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.
CureVac
CureVac
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
Celltrion Healthcare
Celltrion Healthcare
Celltrion Healthcare is a biopharmaceutical company specializing in oncology, influenza, psoriasis, and arthritis.,
3sbio
3sbio
3sbio (三生制药集团) is a company that develops biopharmaceuticals.
Founding Date
Founding Date
2013
Founding Date
2009
Founding Date
2000
Founding Date
2002
Founding Date
1993
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
KR HQ
Locations
Boulder, US HQ
Paris, FR
München, DE
Dublin, IE
Milano, IT
Madrid, ES
Zürich, CH
see more
Locations
Tübingen, DE HQ
Ottignies Louvain La Neuve, BE
Wiesbaden, DE
Amsterdam, NL
Basel, CH
Boston, US
Locations
Incheon, KR HQ
Locations
Shenyang, CN HQ
Employees
Employees
7
Employees
4843% increase
Employees
82517% decrease
Employees
6301% increase
Employees
5,577
Valuation ($)
Valuation ($)
N/A
Valuation ($)
10.6 m
Valuation ($)
648.3 m
Valuation ($)
N/A
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$148.8m (FY, 2021)
Revenue (est.)
€535.2m (FY, 2024)
Revenue (est.)
₩2t (FY, 2022)
Revenue (est.)
¥17.7b (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
€9.7m (FY, 2024)
Cost of goods
₩1.4t (FY, 2022)
Cost of goods
¥818m (FY, 2025)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
€534.4m (FY, 2024)
Gross profit
₩664.7b (FY, 2022)
Gross profit
¥17b (FY, 2025)
Net income
Net income
N/A
Net income
($264.5m) (FY, 2021)
Net income
€162.2m (FY, 2024)
Net income
₩147.2b (FY, 2022)
Net income
¥9.1b (FY, 2025)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 357m
Total funding raised
$ 1.1b
Total funding raised
N/A
Total funding raised
$ 15.2m
For sources of this data, please see the company profile

View Company Profiles

Clovis Oncology
HQ
Boulder, US
Employees
484↑ 3% increase

Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.

View company
CureVac
HQ
Tübingen, DE
Employees
825↓ 17% decrease

CureVac is a biotechnology company offering messenger RNA (mRNA) technology.

View company
Celltrion Healthcare
HQ
Incheon, KR
Employees
630↑ 1% increase

Celltrion Healthcare is a biopharmaceutical company specializing in oncology, influenza, psoriasis, and arthritis.,

View company
3sbio
HQ
Shenyang, CN
Employees
5,577

3sbio (三生制药集团) is a company that develops biopharmaceuticals.

View company